All Stories

  1. Serum selenoprotein P concentrations and cardiovascular disease: results from a large, prospective cohort study of older German adults
  2. Monitoring copper ions in C. elegans using porphyrin phosphonic acids
  3. Trace element-linked DNA methylation sites and their association with type 2 diabetes and cardiovascular diseases: EPIC-Potsdam cohort study
  4. Vitamin A acts as a potent suppressor of selenoprotein P with potential relevance for multivitamin supplementation
  5. Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies
  6. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
  7. Editorial: Thyroid hormones and diet
  8. Dysregulation of hepatic deiodinase type I in metabolically associated steatotic liver disease
  9. Trace elements and risk of diabetes-related vascular complications: results from the EPIC-Potsdam cohort study
  10. Colorectal cancer mortality is associated with low selenoprotein P status at diagnosis
  11. Selenium and Coenzyme Q10 Supplementation and Sex Differences in Cardiovascular Mortality Results from a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly People Low in Selenium
  12. Trace Element Deficiency in Axial Spondyloarthritis and Psoriatic Arthritis in Relation to Markers of Inflammation and Remission
  13. Low blood levels of selenium, selenoprotein P and GPx3 are associated with accelerated biological aging: results from the Berlin Aging Study II (BASE-II)
  14. Serum CD5L Responds Positively to Selenium and Coenzyme Q10 Supplementation with Relation to Thyroid Hormones, Mortality, and Health-Related Quality-of-Life—A Sub-Analysis of a Double-Blind Randomised Placebo-Controlled Trial in Elderly Low in Selenium
  15. Selenoprotein P as a prognostic biomarker of burn sepsis: A prospective cohort study
  16. Total and Free Zinc Dynamics as Biomarkers for Neurological Impairment in Traumatic Spinal Cord Injury
  17. Serum selenium, selenoprotein P and glutathione peroxidase 3 in rheumatoid, psoriatic, juvenile idiopathic arthritis, and osteoarthritis
  18. An expert consensus statement on biomarkers of ageing for use in intervention studies
  19. Circulating Glutathione Peroxidase-3 in Elderly—Association with Renal Function, Cardiovascular Mortality, and Impact of Selenium and Coenzyme Q10 Supplementation
  20. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance
  21. A systematic review of Selenium as a complementary treatment in cancer patients
  22. Low Levels of Selenoprotein P Are Associated With Cognitive Impairment in Patients Hospitalized for Heart Failure
  23. The association between selenium status and global and attention-specific cognition in very old adults in the Newcastle 85+ Study: cross-sectional and longitudinal analyses
  24. Serum CD5L as potential biomarker of thyroid hormone status during pregnancy
  25. Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
  26. Selenium, diabetes, and their intricate sex-specific relationship
  27. Selenoprotein P increases upon selenium and coenzyme Q10 supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
  28. New-onset autoantibodies to selenoprotein P following severe burn injury
  29. Maternal selenium deficiency during pregnancy in association with autism and ADHD traits in children: The Odense Child Cohort
  30. Detection of natural autoimmunity to ghrelin in diabetes mellitus
  31. Correspondence
  32. Identification of Human TRIAC Transmembrane Transporters
  33. Determination of copper status by five biomarkers in serum of healthy women
  34. Comment on Ambra et al. Could Selenium Supplementation Prevent COVID-19? A Comprehensive Review of Available Studies. Molecules 2023, 28, 4130
  35. Comparative investigation of selenium-enriched Pleurotus ostreatus and Ganoderma lucidum as natural sources of selenium supplementation
  36. Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice
  37. Selenium supplementation and placebo are equally effective in improving quality of life in patients with hypothyroidism
  38. Strong associations of serum selenoprotein P with all-cause mortality and mortality due to cancer, cardiovascular, respiratory and gastrointestinal diseases in older German adults
  39. Association between low selenoprotein P concentrations and anaemia in hospitalized heart failure patients
  40. Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial
  41. Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort
  42. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
  43. Serum Selenium-Binding Protein 1 (SELENBP1) in Burn Injury: A Potential Biomarker of Disease Severity and Clinical Course
  44. Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study
  45. Combined copper and zinc deficiency is associated with reduced SARS-CoV-2 immunization response to BNT162b2 vaccination
  46. Selenoprotein P deficiency is associated with higher risk of incident heart failure
  47. Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
  48. Are Twin Pregnancies at Higher Risk for Iron and Calcium Deficiency than Singleton Pregnancies?
  49. Sex-specific associations of serum selenium and selenoprotein P with type 2 diabetes mellitus and hypertension in the Berlin Aging Study II
  50. Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone
  51. A fluorometric assay to determine labile copper(II) ions in serum
  52. Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
  53. Iodine deficiency and real-life supplementation ineffectiveness in Polish pregnant women and its impact on thyroid metabolism
  54. Excessive copper impairs intrahepatocyte trafficking and secretion of selenoprotein P
  55. Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction
  56. Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure
  57. A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance
  58. Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
  59. Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients
  60. Trace element equilibrium in acute heart failure and the effect of empagliflozin
  61. High throughput drug screening identifies resveratrol as suppressor of hepatic SELENOP expression
  62. Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts
  63. Fatal congenital copper transport defect caused by a homozygous likely pathogenic variant of SLC31A1
  64. Association of COVID-19 mortality with serum selenium, zinc and copper: Six observational studies across Europe
  65. Seizures, ataxia and parvalbumin-expressing interneurons respond to selenium supply in Selenop-deficient mice
  66. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status
  67. Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
  68. Assessment of the Effect of Selenium Supplementation on Production of Selected Cytokines in Women with Hashimoto’s Thyroiditis
  69. Increased Incidence of Hashimoto Thyroiditis in Selenium Deficiency: A Prospective 6-Year Cohort Study
  70. Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
  71. Autoimmunity to selenoprotein P predicts breast cancer recurrence
  72. Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2
  73. Selenium Status in Paediatric Patients with Neurodevelopmental Diseases
  74. Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
  75. Free Zinc as a Predictive Marker for COVID-19 Mortality Risk
  76. Editorial: Selenium and Selenoproteins in Brain Development, Function, and Disease
  77. Selenium Deficiency in COVID-19—A Possible Long-Lasting Toxic Relationship
  78. High‐dose supplementation of selenium in left ventricular assist device implant surgery: A double‐blinded, randomized controlled pilot trial
  79. Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
  80. Natural Autoimmunity to Selenoprotein P Impairs Selenium Transport in Hashimoto’s Thyroiditis
  81. Insulin Receptor Autoantibody–mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease
  82. Pronounced Trace Element Variation in Follicular Fluids of Subfertile Women Undergoing Assisted Reproduction
  83. Relationship between Vitamin D Status and Antibody Response to COVID-19 mRNA Vaccination in Healthy Adults
  84. Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
  85. The Nutritional Supply of Iodine and Selenium Affects Thyroid Hormone Axis Related Endpoints in Mice
  86. Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations
  87. Ageing-associated effects of a long-term dietary modulation of four trace elements in mice
  88. Course and Survival of COVID-19 Patients with Comorbidities in Relation to the Trace Element Status at Hospital Admission
  89. Copper Isotopes and Copper to Zinc Ratio as Possible Biomarkers for Thyroid Cancer
  90. Maternal Thyroid Hormone Programs Cardiovascular Functions in the Offspring
  91. Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19—A Preventable Trigger for Autoimmune Disease
  92. Positive effects of selenium supplementation in women with newly diagnosed Hashimoto's thyroiditis in an area with low selenium status
  93. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS
  94. Relation of Serum Copper Status to Survival in COVID-19
  95. Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury
  96. Predicting neurological recovery after traumatic spinal cord injury by time-resolved analysis of monocyte subsets
  97. Relation of Serum Copper Status to Survival in COVID-19
  98. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  99. Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
  100. Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-arm RCT
  101. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial
  102. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  103. Selenium Status Should Be Assessed
  104. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
  105. Serum Selenium Status as a Diagnostic Marker for the Prognosis of Liver Transplantation
  106. PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
  107. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
  108. Serum Selenium Status as Diagnostic Marker for Prognosis in Liver Transplantation
  109. Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease
  110. Se Status Prediction by Food Intake as Compared to Circulating Biomarkers in a West Algerian Population
  111. Copper interferes with selenoprotein synthesis and activity
  112. Selenium deficiency is linearly associated with hypoglycemia in healthy adults
  113. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case‐control study
  114. Selenium Deficiency Is Associated with Mortality Risk from COVID-19
  115. Selenium Deficiency is Associated with Mortality Risk from COVID-19
  116. Aging affects sex- and organ-specific trace element profiles in mice
  117. Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
  118. CD5L Constitutes a Novel Biomarker for Integrated Hepatic Thyroid Hormone Action
  119. Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury
  120. Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite
  121. Copper and selenium status as biomarkers of neonatal infections
  122. Cross-sectional analysis of trace element status in thyroid disease
  123. Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength
  124. Selenium and Selenoprotein P Deficiency Correlates With Complications and Adverse Outcome After Major Trauma
  125. Selenium and copper status - potential signposts for neurological remission after traumatic spinal cord injury
  126. N- and O-Acetylated 3-Iodothyronamines Have No Metabolic or Thermogenic Effects in Male Mice
  127. The other view: the trace element selenium as a micronutrient in thyroid disease, diabetes, and beyond
  128. Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
  129. The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study
  130. Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers
  131. You’d Better Zinc—Trace Element Homeostasis in Infection and Inflammation
  132. Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery
  133. A Zinpyr-1-based Fluorimetric Microassay for Free Zinc in Human Serum
  134. Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
  135. Selenium in Cardiac Surgery
  136. Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
  137. Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status
  138. Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death
  139. Relation of selenium status to neuro-regeneration after traumatic spinal cord injury
  140. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer
  141. Whole Blood Selenium Levels and Selenium Supplementation in Patients Treated in a Family Doctor Practice in Golßen (State of Brandenburg, Germany): A Laboratory Study
  142. Role of Selenium Intake for Risk and Development of Hyperthyroidism
  143. Selenium in Radiation Oncology—15 Years of Experiences in Germany
  144. Cow Milk Consumption Increases Iodine Status in Women of Childbearing Age in a Randomized Controlled Trial
  145. In vivo Effects of Repeated Thyronamine Administration in Male C57BL/6J Mice
  146. Severe selenium deficits in pregnant women irrespective of autoimmune thyroid disease in an area with marginal selenium intake
  147. Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism
  148. Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P
  149. Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  150. Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy
  151. The missing link? The potential role of selenium in the development of liver cancer and significance for the general population
  152. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P
  153. Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections
  154. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans
  155. Trace element and cytokine concentrations in patients with Fibrodysplasia Ossificans Progressiva (FOP): A case control study
  156. Dietary Selenium and Human Health
  157. A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity
  158. Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients
  159. Selenoprotein Gene Nomenclature
  160. Factors impacting the aminoglycoside-induced UGA stop codon readthrough in selenoprotein translation
  161. Positive correlation of thyroid hormones and serum copper in children with congenital hypothyroidism
  162. Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X
  163. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  164. Selenium status in neonates with connatal infection
  165. Selenium Status Is Positively Associated with Bone Mineral Density in Healthy Aging European Men
  166. Association of antiepileptic drug usage, trace elements and thyroid hormone status
  167. Silychristin, a Flavonolignan Derived From the Milk Thistle, Is a Potent Inhibitor of the Thyroid Hormone Transporter MCT8
  168. Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy
  169. Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease
  170. Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine
  171. Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters
  172. Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure
  173. Revised reference values for selenium intake
  174. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases
  175. A Nonradioactive Uptake Assay for Rapid Analysis of Thyroid Hormone Transporter Function
  176. Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds
  177. Gene-specific regulation of hepatic selenoprotein expression by interleukin-6
  178. Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks׳ gestation in nulliparous women who subsequently develop preeclampsia
  179. IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo
  180. Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries
  181. Secisbp2 Is Essential for Embryonic Development and Enhances Selenoprotein Expression
  182. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort
  183. Multicenter, Phase III Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  184. Selenoprotein P is the essential selenium transporter for bones
  185. Hypoxia reduces and redirects selenoprotein biosynthesis
  186. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality
  187. Resting Energy Expenditure and the Effects of Muscle Wasting in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF)
  188. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies
  189. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study,,
  190. Serum selenium is low in newly diagnosed Graves’ disease: a population-based study
  191. Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial
  192. Identification of thyroid hormone response elements in vivo using mice expressing a tagged thyroid hormone receptor α1
  193. Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study
  194. Autoantibodies to the IGF1 Receptor in Graves' Orbitopathy
  195. Bone Turnover and Bone Mineral Density Are Independently Related to Selenium Status in Healthy Euthyroid Postmenopausal Women
  196. Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate Cancer
  197. Standardization of Misleading Immunoassay Based 25-Hydroxyvitamin D Levels with Liquid Chromatography Tandem-Mass Spectrometry in a Large Cohort Study
  198. Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients
  199. Thyroid Function Is Maintained Despite Increased Oxidative Stress in Mice Lacking Selenoprotein Biosynthesis in Thyroid Epithelial Cells
  200. Identification of Iopanoic Acid as Substrate of Type 1 Deiodinase by a Novel Nonradioactive Iodide-Release Assay
  201. Serum copper as a novel biomarker for resistance to thyroid hormone
  202. Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture
  203. Selenium, selenoproteins and the thyroid gland: interactions in health and disease
  204. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture
  205. Differential responses to selenomethionine supplementation by sex and genotype in healthy adults
  206. Disorders of selenium metabolism and selenoprotein function
  207. Determinants of selenium status in healthy adults
  208. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency
  209. Ovine pulmonary adenocarcinoma as an animal model of progressive lung cancer and the impact of nutritional selenium supply
  210. Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage
  211. Activation of mitochondrial energy metabolism protects against cardiac failure
  212. Effects of Selenium Status and Polymorphisms in Selenoprotein Genes on Prostate Cancer Risk in a Prospective Study of European Men
  213. Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  214. Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice
  215. Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain
  216. Selenoprotein-Related Disease in a Young Girl Caused by Nonsense Mutations in theSBP2Gene
  217. The choice of biomarkers determines the selenium status in young German vegans and vegetarians
  218. Genetics and phenomics of selenoenzymes—How to identify an impaired biosynthesis?
  219. Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice
  220. Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
  221. Opposing effects of dietary sugar and saturated fat on cardiovascular risk factors and glucose metabolism in mitochondrially impaired mice
  222. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon
  223. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration
  224. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium
  225. Serum selenium and selenoprotein P status in adult Danes – 8-year followup
  226. Selenium in Oncology: From Chemistry to Clinics
  227. Reduced Serum Selenoprotein P Concentrations in German Prostate Cancer Patients
  228. Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads
  229. Interference of Endocrine Disrupters with Thyroid Hormone Receptor–Dependent Transactivation
  230. Selenium Supplementation Fails to Correct the Selenoprotein Synthesis Defect in Subjects with SBP2 Gene Mutations
  231. Down‐regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
  232. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health
  233. V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis
  234. Think globally: Act locally
  235. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum
  236. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice
  237. Effect of age on sexually dimorphic selenoprotein expression in mice
  238. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3
  239. Neuronal and ependymal expression of selenoprotein P in the human brain
  240. Selenium-Dependent Pre- and Posttranscriptional Mechanisms Are Responsible for Sexual Dimorphic Expression of Selenoproteins in Murine Tissues
  241. Synthesis and Metabolism of Thyroid Hormones Is Preferentially Maintained in Selenium-Deficient Transgenic Mice
  242. Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans
  243. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice
  244. New insights into the physiological actions of selenoproteins from genetically modified mice
  245. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism
  246. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum
  247. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply
  248. Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney
  249. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic
  250. The Neurobiology of Selenium: Lessons from Transgenic Mice
  251. Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency
  252. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues
  253. Effect of endotoxin on expression of TNF receptors and transport of TNF-α at the blood-brain barrier of the rat
  254. Prolactin-Releasing Peptides Do Not Stimulate Prolactin Release in vivo
  255. Expression and Hormonal Regulation of Coactivator and Corepressor Genes
  256. Regulation of the Adenohypophyseal Thyrotropin-Releasing Hormone-Degrading Ectoenzyme by Estradiol1
  257. Thyrotropin-Releasing Hormone Gene Expression by Anterior Pituitary Cells in Long-Term Cultures Is Influenced by the Culture Conditions and Cell-to-Cell Interactions1
  258. Genomic Organization and Promoter Structure of the Human EXT1 Gene
  259. Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme.
  260. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.